Predictions
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.89
20.01.24
20.01.24
€1.00
20.01.25
20.01.25
-14.81%
03.02.24
03.02.24
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.84
01.10.23
01.10.23
€1.20
01.10.24
01.10.24
-2.17%
15.05.24
15.05.24
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.70
22.08.23
22.08.23
-
22.08.24
22.08.24
15.29%
01.09.23
01.09.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.87
22.08.23
22.08.23
-
22.08.24
22.08.24
4.81%
02.09.23
02.09.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€1.76
22.08.23
22.08.23
-
22.09.23
22.09.23
11.36%
04.09.23
04.09.23
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.00
19.05.23
19.05.23
€2.20
19.05.24
19.05.24
-63.20%
01.10.23
01.10.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.22
11.03.23
11.03.23
€4.60
11.03.24
11.03.24
18.48%
19.05.23
19.05.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.93
09.07.22
09.07.22
€4.00
09.07.23
09.07.23
-40.65%
23.07.22
23.07.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.41
05.12.21
05.12.21
€3.00
05.12.22
05.12.22
-0.78%
21.07.22
21.07.22
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.93
01.11.21
01.11.21
€10.80
01.11.22
01.11.22
-21.90%
05.12.21
05.12.21
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.04
13.11.20
13.11.20
-
13.11.21
13.11.21
104.01%
15.07.21
15.07.21
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.14
29.10.20
29.10.20
-
04.11.21
04.11.21
-2.32%
13.11.20
13.11.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.40
26.10.20
26.10.20
-
29.10.20
29.10.20
-5.99%
29.10.20
29.10.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.31
16.09.20
16.09.20
-
26.10.20
26.10.20
-17.06%
26.10.20
26.10.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.67
15.09.20
15.09.20
-
16.09.20
16.09.20
-6.35%
16.09.20
16.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.05
10.09.20
10.09.20
-
15.09.20
15.09.20
-6.25%
15.09.20
15.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.36
04.09.20
04.09.20
-
10.09.20
10.09.20
-4.91%
10.09.20
10.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.01
02.09.20
02.09.20
-
04.09.20
04.09.20
5.79%
04.09.20
04.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.41
01.09.20
01.09.20
-
02.09.20
02.09.20
-6.18%
02.09.20
02.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.59
31.08.20
31.08.20
-
01.09.20
01.09.20
-2.73%
01.09.20
01.09.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€7.45
27.08.20
27.08.20
-
31.08.20
31.08.20
-11.59%
31.08.20
31.08.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.91
20.08.20
20.08.20
-
27.08.20
27.08.20
7.81%
27.08.20
27.08.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€7.39
17.08.20
17.08.20
-
20.08.20
20.08.20
-6.49%
20.08.20
20.08.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€7.39
15.08.20
15.08.20
€2.40
04.11.21
04.11.21
-6.25%
01.11.21
01.11.21
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected